Revvityブログ
発見から治療までのイノベーションを促進
 
     
    
            
        Latest
      
    
    Optimizing functional genomics research tools by aligning their design with the ongoing evolution of the genome.
Functional Genomic Screening 
October 30, 2025  -  3  min read
       
      Functional Genomic Screening
        Cell panel screens play nicely with CRISPR screens: an integrated approach to drug target discovery.
            July 8, 2025 -
            3 min read
          
          
         
      Small Molecule Drug Discovery
        Optimizing assay duration in cell panel screens for slow-acting therapeutics.
            July 8, 2025 -
            2 min read
          
          
         
      Small Molecule Drug Discovery
        Top tips for getting started with antibody validation using cell lines.
            July 8, 2025 -
            4 min read
          
          
         
       
      Functional Genomic Screening
        Mechanism Supports function: The Dharmacon™ siRNA algorithm 20 years strong.
            July 4, 2025 -
            2 min read
          
          
         
      Functional Genomic Screening
        Beyond the pool: how CRISPR single cell screening can reveal hidden detailed phenotypic insights.
            July 4, 2025 -
            2 min read
          
          
         
      Functional Genomic Screening
        How to combine functional genomic and cell panel screening to identify novel targets.
            July 4, 2025 -
            3 min read
          
          
         
       
      Neuroscience Research
        High-content conversations: Dr. Francesco Neri, NeuroAge Therapeutics.
            June 27, 2025 -
            3 min read
          
          
         
      NGS
        Extracellular vesicle isolation for small RNA analysis: a methodological review.
            June 26, 2025 -
            4 min read
          
          
         
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                   
                  